Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results

Go back to Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results
(NASDAQ: VRCA) Delayed: 5.69 +0.62 (12.23%)
Previous Close $5.07    52 Week High
Open $5.12    52 Week Low
Day High $5.86    P/E N/A 
Day Low $5.00    EPS
Volume 351,918